Company Overview of Peptimmune, Inc.
Peptimmune, Inc. went Out of Business. Peptimmune, Inc., a clinical stage biotechnology company, develops peptide and peptide-copolymer therapeutics for the treatment of CNS and autoimmune disorders. It provides PI-2301 peptide copolymer for the treatment of multiple sclerosis; and DEEP (Directed Expansion of Epitope Permutations) vaccines for viral, bacterial, and parasitic infectious diseases. Peptimmune, Inc. was founded in 2002 and is based in Cambridge, Massachusetts.
64 Sidney Street
Cambridge, MA 02139
Founded in 2002
Key Executives for Peptimmune, Inc.
Peptimmune, Inc. does not have any Key Executives recorded.
Similar Private Companies By Industry
|Uckele Animal Health Distributing Inc.||United States|
|Brainceuticals, LLC||United States|
|Takeda America Holdings, Inc.||United States|
|Synteract Corporation||United States|
|Charisela Technologies, Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact Peptimmune, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.